Biotechnology

Yubo International Biotech Limited

Yubo International Biotech Limited released FY2025 9 Months Earnings on November 14, 2025 (EST) with actual revenue of USD 0 and EPS of USD -0.0074

Yubo International Biotech Limited released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 0, actual EPS USD -0.0018

Yubo International Biotech Limited released FY2025 Semi-Annual earnings on August 13, 2025, EST with actual revenue USD 0 and actual EPS USD -0.0045

Yubo International Biotech Limited released FY2025 Q2 earnings on August 13 (EST), actual revenue USD 0, actual EPS USD -0.0019

Yubo International Biotech Limited released FY2025 Q1 earnings on May 14 (EST) with actual revenue of USD 0 and EPS of USD -0.0036

Yubo International Biotech Limited released FY2024 Q4 earnings on March 31 (EST), with actual revenue -18 USD and EPS -0.0024 USD

Yubo International Biotech Limited released FY2024 annual earnings on March 31 (EST), actual revenue 3.47 K USD, actual EPS -0.0148 USD

Yubo International Biotech Limited released FY2024 9 Months Earnings on November 13 (EST), actual revenue USD 3.488 K, actual EPS USD -0.0407

Yubo International Biotech Limited released FY2024 Q3 earnings on November 13 (EST) with actual revenue of 0 USD and EPS of -0.0048 USD

Yubo International Biotech Limited released FY2024 Semi-Annual Earnings on August 19, 2024 (EST), with actual revenue of USD 3.488 K and EPS of USD -0.0137

Yubo International Biotech Limited released FY2024 Q1 earnings on May 20 (EST), actual revenue USD 3.488 K, actual EPS USD -0.0314

Yubo International Biotech Limited released FY2023 annual earnings on April 12 (EST), with actual revenue of 604.68 K USD and EPS of -0.0997 USD

Yubo International Biotech Limited released FY2021 Q2 earnings on August 20, 2021 (EST), with actual revenue of 351.47K USD and EPS of -0.0031

A SPAC III Acquisition

PicoCELA

Davis Commodities

Society Pass

ECD Automotive Design

Gauzy

Bristol-Myers Squibb Company

A SPAC III ACQUISITION CORP. COM NPV CL A (SUBS/RTS)02/01/2026

Paranovus ENT Tech

Cue BioPharma

ADMA生物制藥

Kiniksa Pharmaceuticals

Stoke Therapeutics

Rigel制藥

OpGen

福泰制藥

再生元制藥

阿里拉姆制藥

Argenx

百濟神州

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap